Raman Analysis of Saliva as Biomarker of COPD (CORSAI)
Raman Analysis of Saliva From COPD Patients as New Biomarker: AI-based Point-of-care for the Disease Monitoring and Management
Sponsor: Fondazione Don Carlo Gnocchi Onlus
A observational or N/A phase clinical study on Chronic Obstructive Pulmonary Disease, this trial is ongoing. The trial is conducted by Fondazione Don Carlo Gnocchi Onlus and has accumulated 8 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Unknown
-
Feb 2025 — Sep 2025 [monthly]
Unknown
Status: Recruiting → Unknown
-
Sep 2024 — Feb 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
May 2022 — Jul 2024 [monthly]
Recruiting
▶ Show 3 earlier versions
-
Dec 2021 — May 2022 [monthly]
Recruiting
-
Jan 2021 — Dec 2021 [monthly]
Recruiting
-
Dec 2020 — Jan 2021 [monthly]
Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Fondazione Don Carlo Gnocchi Onlus
- Geratherm Respiratory GmbH
- Institut d'Investigacions Biomèdiques August Pi i Sunyer
- Riga Stradins University
- University of Milano Bicocca
For direct contact, visit the study record on ClinicalTrials.gov .